ScholarIQanswers from OpenAlex
Adenosine and Purinergic Signaling
TopicLeading institutions, researchers & key papers
Adenosine and Purinergic Signaling is a topic indexed in ScholarIQ from OpenAlex.
What is known about Adenosine and Purinergic Signaling?
ScholarIQrecord summary
This cluster of papers focuses on the molecular physiology and pharmacology of purinergic signalling, including the role of adenosine receptors, P2X receptors, and nucleotide signalling in immune suppression, inflammation, neuroprotection, and the tumor microenvironment. It explores the potential therapeutic targets related to purinergic signalling.
How many works does Adenosine and Purinergic Signaling have?
ScholarIQindexed works
Adenosine and Purinergic Signaling has 157 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Adenosine and Purinergic Signaling?
ScholarIQopenalex
The OpenAlex for Adenosine and Purinergic Signaling is on the source record.
What are the most-cited papers on Adenosine and Purinergic Signaling?
ScholarIQmost cited works
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
Louise Arseneault, Mary Cannon, R. Poulton, Robin Murray, Avshalom Caspi, Terrie E. Moffitt
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression
Giovanna Borsellino, Markus Kleinewietfeld, Diletta Di Mitri, Alexander Sternjak, Adamo Diamantini, Raffaella Giometto, Sabine Höpner, Diego Centonze, Giorgio Bernardi, Maria Luisa Dell’Acqua, Paolo Maria Rossini, Luca Battistini, Olaf Rötzschke, Kirsten Falk
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
Faraaz B. Chekeni, Michael R. Elliott, Joanna K. Sandilos, Scott F. Walk, Jason M. Kinchen, Eduardo R. Lazarowski, Allison J. Armstrong, Silvia Peñuela, Dale W. Laird, Guy S. Salvesen, Brant E. Isakson, Douglas A. Bayliss, Kodi S. Ravichandran
Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2
Qing Zhou, Dan Yang, Amanda K. Ombrello, Andrey V. Zavialov, Camilo Toro, Anton V. Zavialov, Deborah L. Stone, Jae Jin Chae, Sergio D. Rosenzweig, Kevin Bishop, Karyl S. Barron, Hye Sun Kuehn, Patrycja Hoffmann, Alejandra Negro, Wanxia Li Tsai, Edward W. Cowen, Wuhong Pei, Joshua D. Milner, Christopher Silvin, Theo Heller, David T. Chin, Nicholas J. Patronas, John S. Barber, Chyi‐Chia Richard Lee, Geryl Wood, Alexander Ling, Susan J. Kelly, David E. Kleiner, James C. Mullikin, Nancy J. Ganson, Heidi H. Kong, Sophie Hambleton, Fabio Candotti, Martha Quezado, Katherine R. Calvo, Hawwa Alao, Beverly Barham, Anne Jones, James F. Meschia, Bradford B. Worrall, Scott E. Kasner, Stephen S. Rich, Raphaela Goldbach‐Mansky, Mario Abinun, Elizabeth Chalom, Alisa Gotte, Marilynn Punaro, Virginia Pascual, James Verbsky, Troy R. Torgerson, Nora G. Singer, Timothy R. Gershon, Seza Özen, Ömer Karadağ, Thomas A. Fleisher, Elaine F. Remmers, Shawn M. Burgess, Susan Moir, Massimo Gadina, Raman Sood, Michael S. Hershfield, Manfred Boehm, Daniel L. Kastner, Ivona Aksentijevich
Innate immunity in diabetic kidney disease
Sydney Tang, Wai Han Yiu
Where is Adenosine and Purinergic Signaling research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Adenosine and Purinergic Signaling is open access?
ScholarIQopen access share
40%OPEN ACCESS